drugset / Trial / NCT01888237
High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication
Phase 4
Completed
118 enrolled
Mahidol University
Takeda Pharmaceuticals International, Inc. · collab
RandomizedFactorialOpen-labelTreatment
Summary
The purpose of this study is to compare the efficacy between 1-day high dose PPI-based triple therapy vs. 10-day sequential therapy for Helicobacter pylori eradication in functional dyspepsia patients.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-08
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amoxicillin | Other / unclassified | 1000 mg | — |
| Comparator | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Lansoprazole | Other / unclassified | 30 mg | Oral |
| Subject | Lansoprazole | Other / unclassified | 60 mg | Oral |
| Comparator | Metronidazole | Small molecule | 400 mg | — |